On May 14, 2020 The Association for Accessible Medicines (AAM) filed an amicus brief in the latest constitutional challenge to the Affordable Care Act (ACA), arguing for the survival of biosimilars pathway (BPCIA), even if the individual mandate of the ACA is found unconstitutional.
Access! 2023 + IGBA 2023 Conference - Last chance to register, join us in Orlando, FL on Feb 13-16!